How we Work
ECCO’s strength is the unique reach of its 27 member societies, representing the diversity of the oncology workforce.
That multidisciplinary asset is leveraged in ECCO policy activity by the oversight and scrutiny provided by the ECCO Oncopolicy Committee.
The Committee is chaired by Prof Klaus Meier, ECCO Board Member and President of the European Society of Oncology Pharmacy
ECCO is also advised in its policy activity by its Patient Advisory Committee
Day-to-day conduct of ECCO policy activity is conducted by dedicated staff at the ECCO office in Brussels.